Clinical outcome of thymectomy in myasthenia gravis patients: A report from Iran
Background: Myasthenia gravis (MG) is an autoimmune disease affecting acetylcholine postsynaptic receptor of voluntary muscles. Thymectomy is done in these patients and is a mainstay in the treatment of MG; however, the
long-term result of surgery is still controversial. This study dealt with the investigation of the results of thymectomy in treatment, recovery and control of the symptoms of these patients.
Methods: This study was performed through a retrospective method in patients suffering from MG who underwent trans-sternal thymectomy between 2011 and 2016. We conducted thymectomy, excision of mediastinal mass and contents of tissues between the right and left phrenic nerves for all patients. Then, the effect of various variables including age, sex, time interval between onset of disease and surgery, thymus pathology and the dosage of drug on clinical response after surgery was determined using various statistical tests.
Results: 47 patients including 26 men and 21 women with the mean age of 33.0 ± 4.6 years have been investigated. The mean age of patients was 36.2 and 29.7 in men and women respectively (P = 0.041). Spiral chest computed tomography (CT) scan was present in 47 patients demonstrating mediastinal mass in 40 (85.1%) patients. Also, our pathological results showed thymic cells in aortopulmonary window contents of 4 patients. According to the results, the younger age of patients at the time of surgery, shorter time between diagnosis and thymectomy, being a woman and non-thymoma pathology were along with better clinical outcomes after thymectomy.
Conclusion: Our study shows better clinical results of thymectomy in patients with normal chest CT scan and normal or atrophic thymus in pathologic reports. Generally, it seems that performing thymectomy in a shorter time interval after diagnosis of MG is beneficial. Moreover, in MG patients who do not suffer from thymoma, it is along with positive results.
2. Liu Z, Lai Y, Yao S, Feng H, Zou J, Liu W, et al. Clinical outcomes of thymectomy in myasthenia gravis patients with a history of crisis. World J Surg 2016; 40(11): 2681-7.
3. Ng JK, Ng CS, Underwood MJ, Lau KK. Does repeat thymectomy improve symptoms in patients with refractory myasthenia gravis? Interact Cardiovasc Thorac Surg 2014; 18(3): 376-80.
4. Cea G, Benatar M, Verdugo RJ, Salinas RA. Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev 2013; (10): CD008111.
5. Siwachat S, Tantraworasin A, Lapisatepun W, Ruengorn C, Taioli E, Saeteng S. Comparative clinical outcomes after thymectomy for myasthenia gravis: Thoracoscopic versus trans-sternal approach. Asian J Surg 2016.
6. Baseer A, Bilal A. Clinical outcome after thymectomy with or without plasmapheresis in patient with myasthenia gravis. Pak J Chest Med 2012; 18(3): 17-23.
7. Ambrogi V, Mineo TC. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis. J Thorac Cardiovasc Surg 2012; 143(3): 601-6.
8. de Perrot M, Donahoe L. Thymectomy for myasthenia gravis: What's next? J Thorac Dis 2017; 9(2): 237-9.
9. Aydin Y, Ulas AB, Mutlu V, Colak A, Eroglu A. Thymectomy in myasthenia gravis. Eurasian J Med 2017; 49(1): 48-52.
10. Waitande SS, Thankachen R, Philip MA, Shukla V, Korula RJ. Surgical outcome of thymectomy for myasthenia gravis. Indian J Thorac Cardiovasc Surg 2007; 23(2): 171-5.
11. Spillane J, Hayward M, Hirsch NP, Taylor C, Kullmann DM, Howard RS. Thymectomy: Role in the treatment of myasthenia gravis. J Neurol 2013; 260(7): 1798-801.
12. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 2016; 375(6): 511-22.
13. Lee CY, Kim DJ, Lee JG, Park IK, Bae MK, Chung KY. Bilateral video-assisted thoracoscopic thymectomy has a surgical extent similar to that of transsternal extended thymectomy with more favorable early surgical outcomes for myasthenia gravis patients. Surg Endosc 2011; 25(3): 849-54.
14. Beers MH, Berkow R. The merck manual of diagnosis and therapy. 17th ed. New York, NY: Wiley; 1999.
15. Muppidi S, Wolfe GI, Conaway M, Burns TM. MG-ADL: Still a relevant outcome measure. Muscle Nerve 2011; 44(5): 727-31.
16. Ruckert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: A cohort study. J Thorac Cardiovasc Surg 2011; 141(3): 673-7.
17. Hatton PD, Diehl JT, Daly BD, Rheinlander HF, Johnson H, Schrader JB, et al. Transsternal radical thymectomy for myasthenia gravis: A 15-year review. Ann Thorac Surg 1989; 47(6): 838-40.
18. Gronseth GS, Barohn RJ. Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the quality standards subcommittee of the American academy of neurology. Neurology 2000; 55(1):
19. Aghajanzadeh M, Khoshrang H, Mohammadzadeh A, Roudbari SA, Ghayeghran AR. Thymectomy for myasthenia gravis: Prognostic factors in 70 patients. Asian Cardiovasc Thorac Ann 2007; 15(5): 371-5.
20. Huang CS, Hsu HS, Huang BS, Lee HC, Kao KP, Hsu WH, et al. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol Scand 2005; 112(2): 108-14.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.